πŸ‡ΊπŸ‡Έ FDA
Patent

US 12121571

Recombinant L-asparaginase

granted A61KA61K38/50A61K9/0019

Quick answer

US patent 12121571 (Recombinant L-asparaginase) held by Jazz Pharmaceuticals Ireland Limited expires Mon Oct 17 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Jazz Pharmaceuticals Ireland Limited
Grant date
Tue Oct 22 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 17 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
32
CPC classes
A61K, A61K38/50, A61K9/0019, A61P, A61P1/00